Cohance Lifesciences Limited
1,218words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
89.83%
Rs. Crore 5 Financial Snapshot Q4FY22 FY22 Growth in Revenue Growth in EBITDA Growth in PAT 89.83% 201.02% 248.27% 47.27% 68.83% 80.82% 6 Key Ratios Q4FY22 FY22 EBIT to Income EBITDA to
201.02%
e 5 Financial Snapshot Q4FY22 FY22 Growth in Revenue Growth in EBITDA Growth in PAT 89.83% 201.02% 248.27% 47.27% 68.83% 80.82% 6 Key Ratios Q4FY22 FY22 EBIT to Income EBITDA to Income P
248.27%
ancial Snapshot Q4FY22 FY22 Growth in Revenue Growth in EBITDA Growth in PAT 89.83% 201.02% 248.27% 47.27% 68.83% 80.82% 6 Key Ratios Q4FY22 FY22 EBIT to Income EBITDA to Income PAT to In
47.27%
apshot Q4FY22 FY22 Growth in Revenue Growth in EBITDA Growth in PAT 89.83% 201.02% 248.27% 47.27% 68.83% 80.82% 6 Key Ratios Q4FY22 FY22 EBIT to Income EBITDA to Income PAT to Income 56
68.83%
Q4FY22 FY22 Growth in Revenue Growth in EBITDA Growth in PAT 89.83% 201.02% 248.27% 47.27% 68.83% 80.82% 6 Key Ratios Q4FY22 FY22 EBIT to Income EBITDA to Income PAT to Income 56.51% 58
80.82%
FY22 Growth in Revenue Growth in EBITDA Growth in PAT 89.83% 201.02% 248.27% 47.27% 68.83% 80.82% 6 Key Ratios Q4FY22 FY22 EBIT to Income EBITDA to Income PAT to Income 56.51% 58.60% 45
56.51%
7% 68.83% 80.82% 6 Key Ratios Q4FY22 FY22 EBIT to Income EBITDA to Income PAT to Income 56.51% 58.60% 45.05% 48.32% 50.91% 37.01% 7 Financials Q4FY22 Revenue EBIDTA PAT EPS 4,983 4,
58.60%
3% 80.82% 6 Key Ratios Q4FY22 FY22 EBIT to Income EBITDA to Income PAT to Income 56.51% 58.60% 45.05% 48.32% 50.91% 37.01% 7 Financials Q4FY22 Revenue EBIDTA PAT EPS 4,983 4,001 2,5
45.05%
2% 6 Key Ratios Q4FY22 FY22 EBIT to Income EBITDA to Income PAT to Income 56.51% 58.60% 45.05% 48.32% 50.91% 37.01% 7 Financials Q4FY22 Revenue EBIDTA PAT EPS 4,983 4,001 2,592 N M
48.32%
ey Ratios Q4FY22 FY22 EBIT to Income EBITDA to Income PAT to Income 56.51% 58.60% 45.05% 48.32% 50.91% 37.01% 7 Financials Q4FY22 Revenue EBIDTA PAT EPS 4,983 4,001 2,592 N M S E E P
50.91%
s Q4FY22 FY22 EBIT to Income EBITDA to Income PAT to Income 56.51% 58.60% 45.05% 48.32% 50.91% 37.01% 7 Financials Q4FY22 Revenue EBIDTA PAT EPS 4,983 4,001 2,592 N M S E E P U R N M
37.01%
2 FY22 EBIT to Income EBITDA to Income PAT to Income 56.51% 58.60% 45.05% 48.32% 50.91% 37.01% 7 Financials Q4FY22 Revenue EBIDTA PAT EPS 4,983 4,001 2,592 N M S E E P U R N M S E E P
Advertisement